MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2019 International Congress

    Neuroradiological differences between patients with akinesia-dominant and tremor-dominant Parkinson’s disease

    KO. Ohta, TN. Nakajima (Kashiwazaki, Japan)

    Objective: To compare the metabolism of the putamen and the cerebral cortex between the akinesia-dominant group and the tremor-dominant group of Parkinson's disease (PD) patients.…
  • 2019 International Congress

    Prospective study of cognition in SCA2

    T. Monte, E. Reckziegel, M. Augustin, O. Barsottini, JL. Pedroso, F. Vargas, ML. Saraiva-Pereira, V. Leotti, L. Jardim (Porto Alegre, Brazil)

    Objective: Evaluate prospectively cognitive dysfunction in subjects with SCA2 using Mini Mental Examination (MMSE) and Montreal Cognition Assesment (MOCA), looking for correlation between cognitiion and motor…
  • 2019 International Congress

    Identifying perceptual, motor and cognitive components contributing to the slowness of information processing in Parkinson’s disease and the implication in the quality of life

    A. Arroyo, J. Andreo, J. Periañez, G. Lubrini, M. Rios, JP. Romero (Pozuelo de Alarcon, Spain)

    Objective: To identify, through tasks of reaction times (RT), the motor, cognitive and perceptual components involved in the processing of information in PD and to…
  • 2019 International Congress

    Identification of protein biomarker/s in CSF of Parkinson’s disease (PD) with cognitive impairment

    A. Naskar, A. Stezin, D. Gadara, S. Ahuja, V. Menon, N. Kamble, J. Saini, S. Hegde, U. Tatu, P. Pal, P. Alladi (Bangalore, India)

    Objective: i. To identify CSF protein biomarker/s in Parkinson's disease (PD) with cognitive impairment using LC-MS/MS proteomics. ii. To estimate the level of known AD…
  • 2019 International Congress

    Exploring the cognitive workload during a visual search task in Parkinson’s disease

    M. Ranchet, J. Morgan, A. Akinwuntan, H. Devos (Kansas City, KS, USA)

    Objective: To investigate cognitive workload during a visual search task in patients with Parkinson's Disease (PD) Background: Visual search is one of the most important…
  • 2019 International Congress

    Neural correlates of Level-1 and Level-2 diagnostic criteria for Mild Cognitive Impairment in Parkinson´s disease.

    I. Aracil-Bolaños, F. Sampedro, J. Marín-Lahoz, A. Horta-Barba, S. Martínez-Horta, JM. González-de-Echávarri, J. Pérez-Pérez, H. Bejr-Kasem, B. Pascual-Sedano, MA. Boti, A. Campolongo, C. Izquierdo, A. Gironell, B. Gómez-Ansón, J. Pagonabarraga, J. Kulisevksy (Barcelona, Spain)

    Objective: To profile the neural correlates of neuropsychological assessment according to the Movement Disorders Society Task Force Criteria in its Level-1 and Level-2 recommendations Background:…
  • 2019 International Congress

    The Promise of Automation: Development and preliminary testing of a language-based machine learning algorithm in PD

    B. Fujii, R. Richter, A. Roberts (Evanston, IL, USA)

    Objective: The proposed work seeks to expand current machine learning algorithms in PD using both motor and language features to discriminate affected speakers from healthy…
  • 2019 International Congress

    Neuropsychological changes over the first 6 years of Parkinson’s disease in the ICICLE-PD cohort

    R. Lawson, G. Duncan, T. Khoo, D. Breen, M. Camacho, C. Williams-Gray, R. Barker, L. Rochester, D. Burn, A. Yarnall (Newcastle Upon Tyne, United Kingdom)

    Objective: To determine the longitudinal differences in cognitive tests in participants with Parkinson’s disease (PD), and the neuropsychological tests most sensitive to change over and…
  • 2019 International Congress

    Identifying subtypes of Mild Cognitive Impairment in Parkinson’s disease using cluster analysis

    D. Pourzinal, JH. Yang, G. Byrne, J. O'Sullivan, L. Mitchell, K. Mcmahon, D. Copland, N. Dissanayaka (St Lucia, Australia)

    Objective: To identify cognitive phenotypes within Parkinson’s disease (PD) and compare them to the current Movement Disorder Society (MDS) diagnostic standards for Mild Cognitive Impairment…
  • 2019 International Congress

    Mild Cognitive Impairment in Young Onset Parkinson Disease

    A. Troster, C. Schweer (Phoenix, AZ, USA)

    Objective: To identify the prevalence of Parkinson disease mild cognitive impairment (PD-MCI) in a group of persons with young onset Parkinson disease (YOPD) consecutively referred…
  • « Previous Page
  • 1
  • …
  • 62
  • 63
  • 64
  • 65
  • 66
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley